Morse Asset Management, Inc Ligand Pharmaceuticals Inc Transaction History

Morse Asset Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$107.38 - $129.34 $873,536 - $1.05 Million	-8,135 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$105.93 - $142.47 $118,111 - $158,854	-1,115 Reduced 12.05%	8,135 $1.02 Million
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $93,702 - $198,654	-730 Reduced 7.31%	9,250 $1.26 Million
Q3 2018 Nov 01, 2018	BUY	$211.18 - $274.49 $21,118 - $27,449	100 Added 1.01%	9,980 $2.74 Million
Q2 2018 Aug 15, 2018	BUY	$150.77 - $207.98 $530,710 - $732,089	3,520 Added 55.35%	9,880 $2.05 Million
Q1 2018 May 02, 2018	BUY	$138.63 - $182.62 $395,788 - $521,380	2,855 Added 81.46%	6,360 $1.05 Million
Q4 2017 Jan 29, 2018	SELL	$128.36 - $147.04 $1.79 Million - $2.05 Million	-13,950 Reduced 79.92%	3,505 $480,000
Q3 2017 Oct 31, 2017	BUY	$120.91 - $137.94 $2.11 Million - $2.41 Million	17,455	17,455 $2.38 Million

276

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.